Scott H Meyer, M.D. Neurological Surgery Medicare: Accepting Medicare Assignments Practice Location: 3931 Louisiana Ave S, St Louis Park, MN 55426 Phone: 952-993-3230 Fax: 952-993-1748 |
Anthony G Bottini, MD Neurological Surgery Medicare: Accepting Medicare Assignments Practice Location: 3931 Louisiana Ave S, St Louis Park, MN 55426 Phone: 952-993-3123 |
Eric C Schenk, Neurological Surgery Medicare: Not Enrolled in Medicare Practice Location: 3931 Louisiana Ave S, Ste E500, St Louis Park, MN 55426 Phone: 952-993-7342 Fax: 952-993-2701 |
Dr. Brent Bauman, M.D. Neurological Surgery Medicare: Accepting Medicare Assignments Practice Location: 3931 Louisiana Ave S, St Louis Park, MN 55426 Phone: 952-993-3230 |
Dr. Charles Reginald Watts, M.D. Neurological Surgery Medicare: Accepting Medicare Assignments Practice Location: 3931 Louisiana Ave S, St Louis Park, MN 55426 Phone: 952-993-3230 Fax: 952-993-1748 |
Mr. Albert Louis Meric Iii, MD Neurological Surgery Medicare: Accepting Medicare Assignments Practice Location: 3931 Louisiana Ave S, Suite East 500, St Louis Park, MN 55426 Phone: 952-993-2079 Fax: 952-993-2701 |
News Archive
Ultrasound is often used as a first-line diagnostic exam to quickly and safely diagnose a range of patient conditions. At this year's American Society of Echocardiography (ASE) annual meeting in Montreal, June 11-14, 2011, Toshiba America Medical Systems, Inc., will highlight cardiac and shared service ultrasound applications designed to improve cardiac ultrasound imaging.
Medical device pioneer Stentys announced today that the complete ‘OPEN-I' clinical study was presented by Stefan Verheye, M.D., Ph.D., at the Joint Interventional Meeting ("JIM") 2010 in Rome, demonstrating superior results in 60 patients (27 Stentys drug-eluting stents and 33 Stentys bare-metal stents) who were followed–up angiographically after six months.
Micromet, Inc., a biopharmaceutical company developing novel, proprietary antibodies for the treatment of cancer, inflammation and autoimmune diseases, today announced the publication of a poster with new data from its ongoing phase 1 clinical trial of its product candidate blinatumomab in patients with non-Hodgkin's lymphoma (NHL) at the 51ST Annual Meeting of the American Society of Hematology (ASH) in New Orleans, Louisiana.
A new lecture series at the University of Houston (UH) will give Houstonians an opportunity to learn how science is making a difference in health and medicine. The first of five lectures will be held from 7 to 8 p.m. Wednesday, April 25 at the Hilton University of Houston.
› Verified 2 days ago